|
Team-Based Case Review: Oligometastatic Prostate, Non-Small Cell Lung, and Colorectal Cancers |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Newer Approaches to Treatment of Bladder Cancer |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Management of Immune Checkpoint Inhibitor-Related Toxicities |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Advances in the Treatment of Non-Metastatic Non-Small Cell Lung Cancer |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Treatment for Pleural and Peritoneal Mesothelioma |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Treatment Updates for Small Cell Lung Cancer |
0.50 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Updates in Metastatic Colorectal Cancer |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Remembrance and Renewal: A Holistic Self-Care Program for Oncology Clinicians |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
From Theory to Practice: Building Sustainable, High-Impact Patient Navigation Models |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Recorded Presentations from the NCCN 2025 Annual Conference |
|
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
CRS and ICANS Management in CAR T/Bispecific Antibody Therapies |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Updates in Melanoma: A Focus on Neoadjuvant Approaches |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Ambulatory Care Models |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Financial Toxicity of Cancer Care |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
New Tools for Breast Cancer Risk Assessment |
0.50 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
Facebook
X
LinkedIn
Forward